Gotham has more than 17 years of healthcare industry experience. Prior to joining RTW, Gotham served as CEO of Simran Investment Group, LLC, a privately held equity investment fund.
Before Simran, Gotham was a healthcare portfolio manager and principal at Citadel Investment Group LLC and before that served in various analyst roles at Oracle Partners LP, covering biotechnology and medical device sectors. He began his career on the life sciences investment banking team at Hambrecht & Quist.
I went to medical school wanting to study science and develop a mastery in medicine so that I could help people. At RTW, we go beyond the ‘First Do No Harm’ of the Hippocratic Oath. We venture into new breakthrough areas of medicine and look to support companies working on truly revolutionary concepts. Companies can’t do it alone, and that’s where we come in bringing business expertise and financial backing to help them execute the impossible
Gotham serves on the board of directors of Rocket Pharmaceuticals. He received his MD from the University of Nebraska Medical School and completed the Sarnoff cardiovascular research fellowship at Columbia University, College of Physicians & Surgeons and at Harvard Medical School, Brigham & Women’s Hospital.